Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Primary care physicians' reported use of pre-screening discussions for prostate cancer screening: a cross-sectional survey.

Linder SK, Hawley ST, Cooper CP, Scholl LE, Jibaja-Weiss M, Volk RJ.

BMC Fam Pract. 2009 Mar 18;10:19. doi: 10.1186/1471-2296-10-19.

PMID:
19296843
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Prostate-specific antigen tests and prostate cancer screening: an update for primary care physicians.

Kell JS.

Can J Urol. 2010 Feb;17 Suppl 1:18-25. Review.

PMID:
20170597
[PubMed - indexed for MEDLINE]
3.

Screening for prostate cancer in U.S. men ACPM position statement on preventive practice.

Lim LS, Sherin K; ACPM Prevention Practice Committee.

Am J Prev Med. 2008 Feb;34(2):164-70. doi: 10.1016/j.amepre.2007.10.003. Review. Erratum in: Am J Prev Med. 2008 May;34(5):454.

PMID:
18201648
[PubMed - indexed for MEDLINE]
4.

Minority issues in prostate disease.

French DB, Jones LA.

Med Clin North Am. 2005 Jul;89(4):805-16. Review.

PMID:
15925651
[PubMed - indexed for MEDLINE]
5.

Screening for prostate cancer: the current evidence and guidelines controversy.

Gomella LG, Liu XS, Trabulsi EJ, Kelly WK, Myers R, Showalter T, Dicker A, Wender R.

Can J Urol. 2011 Oct;18(5):5875-83. Review.

PMID:
22018148
[PubMed - indexed for MEDLINE]
Free Article
6.

Trials of decision aids for prostate cancer screening: a systematic review.

Volk RJ, Hawley ST, Kneuper S, Holden EW, Stroud LA, Cooper CP, Berkowitz JM, Scholl LE, Saraykar SS, Pavlik VN.

Am J Prev Med. 2007 Nov;33(5):428-434. Review.

PMID:
17950409
[PubMed - indexed for MEDLINE]
7.

[The participation of primary care physicians in integrated health services network: United States experiences].

de Stampa M, Vedel I, Henrard JC, Bergman H, Novella JL, Lapointe L.

Rev Epidemiol Sante Publique. 2007 Dec;55(6):401-12. Epub 2007 Nov 28. Review. French.

PMID:
18054187
[PubMed - indexed for MEDLINE]
8.

Promoting informed decision making about prostate cancer screening.

Chan EC.

Compr Ther. 2001 Fall;27(3):195-201. Review.

PMID:
11569319
[PubMed - indexed for MEDLINE]
9.

Screening for prostate cancer in asymptomatic men: clinical, legal, and ethical implications.

Gerard MJ, Frank-Stromborg M.

Oncol Nurs Forum. 1998 Oct;25(9):1561-9. Review.

PMID:
9802052
[PubMed - indexed for MEDLINE]
10.

Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.

Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force.

Ann Intern Med. 2008 Aug 5;149(3):192-9. Review.

PMID:
18678846
[PubMed - indexed for MEDLINE]
11.

Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review.

Van der Meer S, Löwik SA, Hirdes WH, Nijman RM, Van der Meer K, Hoekstra-Weebers JE, Blanker MH.

BMC Fam Pract. 2012 Oct 11;13:100. doi: 10.1186/1471-2296-13-100. Review.

PMID:
23052017
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The use of prostate specific antigen for prostate cancer screening: a managed care perspective.

Handley MR, Stuart ME.

J Urol. 1994 Nov;152(5 Pt 2):1689-92. Review.

PMID:
7523716
[PubMed - indexed for MEDLINE]
13.

Prostate cancer screening 2010: updated recommendations from the American Cancer Society.

Brooks DD, Wolf A, Smith RA, Dash C, Guessous I.

J Natl Med Assoc. 2010 May;102(5):423-9. Review.

PMID:
20533778
[PubMed - indexed for MEDLINE]
14.

Using prostate-specific antigen screening and nomograms to assess risk and predict outcomes in the management of prostate cancer.

Hammerer PG, Kattan MW, Mottet N, Prayer-Galetti T.

BJU Int. 2006 Jul;98(1):11-9. Epub 2006 Mar 23. Review.

PMID:
16566811
[PubMed - indexed for MEDLINE]
15.

Informed decision making: what is its role in cancer screening?

Rimer BK, Briss PA, Zeller PK, Chan EC, Woolf SH.

Cancer. 2004 Sep 1;101(5 Suppl):1214-28. Review.

PMID:
15316908
[PubMed - indexed for MEDLINE]
Free Article
16.

Prostate-specific antigen-based screening for prostate cancer: evidence, controversies and future perspectives.

Ito K.

Int J Urol. 2009 May;16(5):458-64. doi: 10.1111/j.1442-2042.2009.02293.x. Epub 2009 Apr 1. Review.

PMID:
19341365
[PubMed - indexed for MEDLINE]
17.

Prostate cancer intervention. Involving the patient in early detection and treatment.

Wilt TJ, Partin MR.

Postgrad Med. 2003 Oct;114(4):43-9; quiz 50. Review. Erratum in: Postgrad Med. 2004 Feb;115(2):7.

PMID:
14587206
[PubMed - indexed for MEDLINE]
18.

Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback.

Ransohoff DF, McNaughton Collins M, Fowler FJ.

Am J Med. 2002 Dec 1;113(8):663-7. Review.

PMID:
12505117
[PubMed - indexed for MEDLINE]
19.

Screening for prostate cancer: who and how often?

Schwartz K, Deschere B, Xu J.

J Fam Pract. 2005 Jul;54(7):586-96. Review.

PMID:
16009085
[PubMed - indexed for MEDLINE]
20.

Diagnosing prostate cancer - what GPs need to know.

Frydenberg M, Wijesinha S.

Aust Fam Physician. 2007 May;36(5):345-7. Review.

PMID:
17492070
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk